EpiPen Direct Buyers, Mylan Ink $75M Antitrust Deal
By Lauren Berg · January 16, 2025, 7:51 PM EST
Mylan Pharmaceuticals has agreed to pay $73.5 million to resolve claims it worked with Pfizer to inflate the price of the latter's popular auto-injecting emergency allergy medication EpiPen, a proposed class...
To view the full article, register now.